Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 86774

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
November 09, 2020
Product types
Device
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Helena Laboratories, Corp.

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 1

K-ACT Actalyke Clotting Test Tubes that are used in the: ACTALYKE XL ACTIVATED CLOTTING TIME ANALYZER, and ACTALYKE MINI ACTIVATED CLOTTING TIME TEST SYSTEM.

Z-0635-2021
Recall number
Z-0635-2021
Initiated
November 09, 2020
Classification
Class II
Status
Ongoing
Quantity
Lot 1-19-K-ACT = 314 tubes and Lot 2-19-K-ACT = 297 tubes

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Due to complaints received associated with cracked/split test tube caps.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Due to complaints received associated with cracked/split test tube caps.

Code information

Catalog Number: K-ACT Lot Number: 1-19-K-ACT and 2-19-K-ACT

Distribution pattern

Worldwide distribution - U.S. Nationwide including in the states of NJ, NY, PA and TX. The countries of Austria, Canada, England, France, Italy, Portugal, Russia, Spain.

Field note

Send feedback

We'll only use this to respond to your feedback.